Recall Register

Food, drugs, devices › Fujifilm Medical Systems U.S.A., Inc.

Device recall: Synapse PACS - Radiological Image Processing System - Product Usage: intended for use, as a web based application, on an

FDA enforcement event 87579 · Class II · initiated 2 Mar 2021 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordLexington, MA

FDA enforcement event 87579 is a device recall by Fujifilm Medical Systems U.S.A., Inc. of Lexington, MA, initiated 2 Mar 2021 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 89% of the 900 device enforcement events initiated in 2021 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Fujifilm Medical Systems U.S.A., Inc. has 27 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Fujifilm Medical Systems U.S.A., Inc., Lexington, MA.

Reason for recall

"The wrong patient information may be displayed in the viewer or PowerJacket."

Distribution

"Worldwide distribution - US Nationwide distribution including in the states of AZ, CA, CO, CT, DC, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NV, NY, OH, OK,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1348-2021Synapse PACS - Radiological Image Processing System - Product Usage: intended for use, as a web based application, on an off-the-shelf PC meeting or exceeding minimum specifications and networked with FUJIFILM Synapse PACS Software (Server).839 systemsClass IIOngoing14 Apr 2021

Context

89%of 2021 device events are Class II900 events that year
1product record in this eventfirm median: 1
27events on this register for the firm

Other enforcement events for Fujifilm Medical Systems U.S.A., Inc.

InitiatedProduct (first record)TypeClassRecords
30 Apr 2021Synapse Cardiovascular (Synapse CV). Software Versions: 6.0 to 6.2.1 The Synapse Cardiovascular image is a management anDeviceClass II1
18 Feb 2021¿TASWako Chip Cassette is part of the Wako ¿TASWako i30 kitDeviceClass II1
22 Dec 2020Wako HDL-C/LDL-C Calibrator - Product Usage: designed to be used with Wako L-Type HDL-C or L-Type LDL-C for the determinDeviceClass III1
11 Dec 2020FUJIFILM Synapse PACS Software: versions 7.0.0 and 7.0.1 - Product Usage: intended for use as a web based application onDeviceClass II1
11 Sep 2020Synapse PACS Software Versions 5.1 and higherDeviceClass II1
11 Sep 2020Synapse PACS Software Version 5.6.1 - Product Usage: intended for use as a web based application on an off-the shelf PC DeviceClass II1
22 May 2020Fujifilm Synapse PACS Software Version 5.5.x and 5.7.x- intended as interface to the FUJIFILM Synapse PACS Software (SerDeviceClass II1
19 Jul 2019Fujifilm FDR Go Plus mobile X-ray systemDeviceClass II1
15 Jan 2019Fujifilm FDR Go PLUS, Mobile X-Ray System Product Usage: This device is intended to be used to take a film, CR or generaDeviceClass II1
4 Aug 2017Aspire HD (for FDR-1000AWS) The Fujifilm Digital Mammography System, Aspire HD (FDR MS-l000), generates full-field digitDeviceClass II4

All 27 events for Fujifilm Medical Systems U.S.A., Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The wrong patient information may be displayed in the viewer or PowerJacket."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide distribution including in the states of AZ, CA, CO, CT, DC, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NV, NY, OH, OK,…"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.